Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / MED BREAKTHGH
-
Total 13F shares
-
1,520,791
-
Share change
-
-5,171
-
Total reported value
-
$73,292,731
-
Put/Call ratio
-
33%
-
Price per share
-
$48.91
-
Number of holders
-
63
-
Value change
-
-$378,747
-
Number of buys
-
28
-
Number of sells
-
26
Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2021
As of 30 Jun 2021,
ALPS ETF TR - MED BREAKTHGH (SBIO) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,520,791 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, WELLS FARGO & COMPANY/MN, Phoenix Holdings Ltd., NTV Asset Management LLC, Cardan Capital Partners, LLC, Tower Research Capital LLC (TRC), LPL Financial LLC, and CITADEL ADVISORS LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.